The present disclosure relates to high protein dietary supplements for treating various symptoms and diseases associated with protein deficiency including weight gain, obesity, catabolic diseases, fibromyalgia, anxiety reactions, posttraumatic stress and chronic fatigue syndrome. Embodiments of diet
The present disclosure relates to high protein dietary supplements for treating various symptoms and diseases associated with protein deficiency including weight gain, obesity, catabolic diseases, fibromyalgia, anxiety reactions, posttraumatic stress and chronic fatigue syndrome. Embodiments of dietary supplements comprise combinations of proteins, essential and semi-essential amino acids including L-Lysine, L-Arginine, and/or L-Histidine.
1. A dietary supplement comprising free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan, wherein the free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan are the only free-form amino acids in the dietary supplement and the dietary supplement comprises between 10 mg and 3 g of each of the free-form amino acids per 16.5 g of dietary supplement. 2. The dietary supplement of claim 1, wherein said dietary supplement is formulated in a powder or liquid form. 3. The dietary supplement of claim 1, wherein said free-form L-Lysine, L-Arginine, or L-Histidine is formulated for sustained or extended release. 4. The dietary supplement of claim 1, further comprising between 1 g and 50 g of at least one protein. 5. The dietary supplement of claim 4, wherein said at least one protein is selected from the group consisting of whey protein, egg protein, casein, and soy protein. 6. A method of improving a condition associated with excess caloric intake in a subject, the method comprising: identifying a subject in need of an improvement in a condition associated with excess caloric intake; andproviding the subject an effective amount of a dietary supplement for a time sufficient to improve the condition associated with excess caloric intake, wherein:the dietary supplement comprises free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan, wherein the free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan are the only free-form amino acids in the dietary supplement and the dietary supplement comprises between 10 mg and 3 g of each of the free-form amino acids per 16.5 g of dietary supplement. 7. The method of claim 6, wherein the condition associated with excess caloric intake is selected from among excess bodyweight, obesity, and morbid obesity. 8. The method of claim 6, wherein the subject has a body mass index (BMI) greater than that of a healthy subject of the same gender and age. 9. The method of claim 1, wherein the subject is provided the dietary supplement for at least 14 consecutive days. 10. A method of reducing body weight, improving skin, hair or nail health, improving neuromuscular activity, improving sexual desire or reproductive capacity, improving immune system function, improving digestive health, reducing the effects of aging, improving muscle bulk, ameliorating symptoms associated with post traumatic stress, improving anxiety reactions, improving nutritional imbalance due to an eating disorder, improving, ameliorating or treating Metabolic Syndrome, or improving the ability prevent or treat addictive drug disorders, the method comprising: identifying a subject in need of improvement in a condition associated with excess body weight, skin, hair or nail health, neuromuscular activity, sexual desire or reproductive capacity, immune system function, digestive health, effects of aging, muscle bulk, symptoms associated with post traumatic stress, anxiety reactions, nutritional imbalance due to an eating disorder, Metabolic Syndrome, or addictive drug disorders; andproviding the subject an effective amount of a dietary supplement for a time sufficient to reduce body weight, improve skin, hair or nail health, improve neuromuscular activity, improve sexual desire or reproductive capacity, improve immune system function, improve digestive health, reduce effects of aging, improve muscle bulk, ameliorate symptoms associated with post traumatic stress, improve anxiety reactions, improve nutritional imbalance due to an eating disorder, improve, ameliorate or treat Metabolic Syndrome, or improve the ability prevent or treat addictive drug disorders; wherein:the dietary supplement comprises free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan, wherein the free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan are the only free-form amino acids in the dietary supplement and the dietary supplement comprises between 10 mg and 3 g of each of the free-form amino acids per 16.5 g of dietary supplement. 11. The method of claim 10, wherein the subject is provided the dietary supplement for at least 14 consecutive days. 12. A method of reducing weight of a subject in need thereof, comprising providing a dietary supplement to the subject for a time sufficient for the weight of the subject to be reduced, wherein: the dietary supplement is formulated in a powder or liquid form and comprises per 16.5 g serving at least 10 mg of each of free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan, wherein the free-form L-Lysine, free-form L-Arginine; free-form L-Histidine, free-form L-Isoleucine, free-form L-Leucine, free-form L-Threonine, free-form L-Valine, free-form dl-Phenylalanine, free-form L-Methionine, and free-form 5-Hydroxy Tryptophan are the only free-form amino acids in the dietary supplement and the dietary supplement comprises between 10 mg and 3 g of each of the free-form amino acids per 16.5 g of dietary supplement. 13. The method of claim 12, wherein the subject is provided the effective amount of the composition for at least 14 consecutive days. 14. The method of claim 12, wherein improving immune system function comprises an increase in natural resistance to a microorganism. 15. The method of claim 12, wherein improving skin or nail hair health comprises increasing hair growth. 16. The method of claim 13, wherein improving anxiety reactions comprises stabilization of mood swings, decrease in depression, decrease in body stress, a more restful sleep, an increase of muscle relaxation, or an improved memory capacity.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (26)
Meezan Elias (Birmingham AL) Pillion Dennis J. (Birmingham AL), Absorption enhancers for drug administration.
N\Guyen Quang L. (Antony FRX) Millecamps Francois (Paris FRX) Galey Jean-Baptiste (Paris FRX), Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated.
George H. Clark ; Mary Ann Clark, Carbonated fortified milk-based beverage and method of making carbonated fortified milk-based beverage for the supplementation of essential nutrients in the human diet.
Beale Paxton K. ; Nickey Donald O. ; Williamson Millard F., Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal.
Gans Arnold M. (Closter NJ) Goren Alvin J. (North Bergen NJ) Gorenberg Eli M. (Fair Lawn NJ), Method of treating obesity by the oral administration of a predigested protein composition.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.